News round-up by DDW’s Reece Armstrong for 23-27 May
UK investment plans, company appointments to drive strategy, and digital health platforms are some of the themes of this week’s news round-up.
New £20m fund launches to support North West life sciences
A new £20 million fund has been launched in the Northwest of England to help support the region’s life sciences sector. The ‘GMC Life Sciences Fund By Praetura’ is a partnership between Greater Manchester Combined Authority (GMCA), Cheshire and Warrington Local Enterprise Partnership (LEP), Bruntwood SciTech and Praetura Ventures.
Calidi granted US patent for immunotherapy platform
Biotechnology company Calidi Biotherapeutics has been granted a US patent for its SuperNova (SNV) technology platform. Calidi’s SNV platform is composed of allogeneic, adipose-derived mesenchymal stem cells (AD-MSC) loaded with an oncolytic agent.
CN Bio appoints Chief Business Officer to drive strategy
Organ-on-a-chip Company (OOC) CN Bio has appointed a new Chief Business Officer as part of its commercial business strategy.
Sidekick Health launches digital platform for atopic dermatitis
Digital therapeutics provider Sidekick Health has launched an integrated solution for improving the outcomes of patients with Atopic Dermatitis (AD). The product was developed in collaboration with Pfizer and will be rolled out in the UK first before being launched in other regions.
Benchling launches beta for biomolecule design
R&D cloud platform provider Benchling has launched a new artificial intelligence (AI) programme to help scientists predict 3D structures of novel proteins.
